johnson & johnson - Search News

Johnson & Johnson Q4 Profit Decreases

Hosted on MSN · 1h

Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the look-back and look-ahead on an earnings call,

Business Insider · 4h

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The

Houston Chronicle · 5h

Johnson & Johnson: Q4 Earnings Snapshot

The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $2 per share. The world's biggest maker of health care products posted revenue of $22.52 billion in the period,

Bears Hire Ben Johnson

USA Today · 1d

Detroit Lions fans crush Ben Johnson for leaving to Chicago Bears: 'Benedict Johnson'

Some Detroit Lions fans are beside themselves that Ben Johnson is staying in the NFC North with the Chicago Bears: 'Benedict Johnson'

The Washington Post · 1d

Ben Johnson agrees to become Bears head coach

Detroit Lions offensive coordinator Ben Johnson has agreed to become the Chicago Bears head coach, a person familiar with the situation told The Associated Press Ben Johnson helped Jared Goff establish himself as one of the NFL’s top quarterbacks.

Bears Wire · 3h

Ben Johnson's 3 most important hires on Bears coaching staff

Now that the head coaching search is over, the actual work begins. The roster needs improving, but it is also very important for the team to make great hires for the rest of the coaching staff. Johnson will certainly be the head decision-maker when it comes to building his group of coaches.

3h

Johnson & Johnson Tops Q4 EPS Forecasts

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

1h

Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Shareholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

21hon MSN

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

3h

J&J Tops Q4 Adjusted Earnings Estimates, But 2025 Sales Outlook Falls Short

Johnson & Johnson posted its fourth-quarter earnings report Wednesday morning, with adjusted profits beating expectations ...

5h

Johnson & Johnson reports Q4 adjusted EPS $2.04, consensus $2.02

Reports Q4 revenue $22.5B, consensus $22.45B. “2024 was a transformative year for Johnson & Johnson, marked by strong growth, an ...

11h

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Johnson & Johnson has secured FDA approval for expanded use of its Spravato nasal spray, now cleared as a standalone ...

TipRanks on MSN3d

Johnson & Johnson’s New Acquisition Could Result in Tremendous Rewards

Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results